HEMOSTASIS AND FUNCTIONAL PROPERTIES OF NEUTROPHILS IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE CORONARY SYNDROME

Material and methods. Totally 53 patients included during the first 24 hours of ACS. Controls consisted of 50 relatively healthy individuals. All patients before the treatment and revascularization were assessed for the resistance to ASA, and selected into groups of sensitive (AS) and resistant (AR). Sensitivity test was done in vitro. In all participants the coagulation and platelet clotting systems were studied. With the luminescent method the neutrophil activity was assessed. Results. In AR with ACS there was decrease of platelets in blood, decreased level of ADP- (ADP 5 mcM) and adrenalin-induced aggregation, increases the level of ADP-induced platelets aggregation (PA) with ADP 0,1 mcM, and von Willebrand factor level. In the ASA sensitive patients there was a decrease of adrenalin induced aggregation.

There were no specifics of coagulation hemostasis according to ASA sensitivity. Chemiluminiscence (CL) of neutrophils in ACS has a maximized out time. In AR there was decrease of activation. In AS functional activity of neutrophils more significantly correlates with the parameters of clotting, but in AR — with fibrinolytic and anticoagulation parameters.

Conclusion. In ACS patients depending on ASA sensitivity, there are character specifics of platelet clotting: increase of ADP-induced aggregation in AR, decrease of platelet amount and the level of von Willebrand factor. In ACS patients there is a decreased velocity of "respiratory boost" in neutrophils. In AR there is more prominent dysbalance of coagulation hemostasis and "respiratory boost" of neutrophils, with the decrease of neutrophil reactivity related to clotting activity and appearance of relations with the parameters of fibrinolytic and anticoagulation activity.

1. Bae MH, Lee JH, Yang DH, et al. White blood cell, hemoglobin and platelet distribution width as short-term prognostic markers in patients with acute myocardial infarction. J Korean Med Sci 2014; 29(4): 519-26.

2. Nahrendorf M, Swirski FK. Imaging systemic inflammation in patients with acute myocardial infarction. Circ Cardiovasc Imaging 2014; 7(5): 762-4.

3. Yoshizaki T, Umetani K, Ino Y et al. Activated inflammation is related to the incidence of atrial fibrillation in patients with acute myocardial infarction. Intern Med 2012; 51(12): 1467-71.

4. Becatti M, Fiorillo C, Gori AM, et al. Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment. Atherosclerosis 2013; 231(2): 392-400.

5. Schmalbach B, Stepanow O, Jochens A, et al. Determinants of Platelet-Leukocyte Aggregation and Platelet Activation in Stroke. Cerebrovasc Dis 2015; 39(3-4): 176-80.

6. Sexton TR, Wallace EL, Macaulay TE, et al. The Effect of Rosuvastatin on Platelet-Leukocyte Interactions in the Setting of Acute Coronary Syndrome. JACC 2015; 65(3): 306-7.

7. Kirtane AJ, Rinaldi M, Parise H, et al. Impact of Point-of-Care Platelet Function Testing among Patients with and without Acute Coronary Syndromes Undergoing PCI with Drug-Eluting Stents: an Adapt-Des Substudy. JACC 2012; 59:E291.

8. Grinshtein YuI, Kosinova AA, Grinshtein IYu. The possible causes and mechanisms of development of secondary acetylsalicylic acid resistance. Rossijskie medicinskie vesti 2013; 2: 4-13. Russian (Гринштейн Ю. И., Косинова А. А., Гринштейн И. Ю. Возможные причины и механизмы развития вторичной резистентности к ацетилсалициловой кислоте. Российские медицинские вести 2013; 2: 4-13).

9. ESC Guidelines For the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.

10. Grinshtein YuI, Filonenko IV, Savchenko AA, et al. A method for diagnosing resistance to acetylsalicylic acid. Patent № 2413953 Russia, MPK G01N 33/86 (2006.01). Published 10.03.2009, Bul. № 7: 8 p. Russian (Гринштейн Ю. И., Филоненко И. В.,

11. Савченко А. А. и др. Способ диагностики резистентности к ацетилсалициловой кислоте. Патент № 2413953 РФ, МПК G01N 33/86 (2006.01). Опубл. 10.03.2009, Бюл. № 7: 8 с).

12. Kolenchukova OA, Savchenko AA, Smirnova SV. Features of luminol- and lucigenin- dependent chemiluminescence of neutrophils in patients with chronic rhinosinusitis. Medical immunology 2010; 12(4-5): 437-40. Russian (Коленчукова О. А., Савченко А. А., Смирнова С. В. Особенности люминол- и люцигенин-зависимой хемилюминесценции нейтрофильных гранулоцитов у больных хроническим риносинуситом. Медицинская иммунология 2010; 12(4-5): 437-40).

13. Kurtasova LM, Savchenko AA, Shkapova EA. Clinical aspects of neutrophil granulocytes functional disorders in cancer pathology. Novosibirsk: Nauka 2009; 183 p. Russian (Куртасова Л. М., Савченко А. А., Шкапова Е. А. Клинические аспекты функциональных нарушений нейтрофильных гранулоцитов при онкопатологии. Новосибирск: Наука 2009; 183 с).

14. Braga PC, Dal Sasso M, Lattuada N, et al. Antioxidant activity of hyaluronic acid investigated by means of chemiluminescence of equine neutrophil bursts and electron paramagnetic resonance spectroscopy. J Vet Pharmacol Ther 2015; 38(1): 48-54.

15. Borna C, Lazarowski E, van Heusden C, et al. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 2005; 3: 10.

16. Chakroun T, Gerotziafas, Robert F, et al. In vitro aspirin resistance detected by PFA- 100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004; 124 (1): 80-5.

17. Shimohina NJu, Savchenko AA, Petrova MM, et al. Features of the hemostatic system and chemiluminescent activity of neutrophilic granulocytes in patients with acute coronary syndrome. Sibirskoe medicinskoe obozrenie 2012; 6: 21-4. Russian (Шимохина Н.Ю., Савченко А. А., Петрова М.М. и др. Особенности системы гемостаза и хемилюми- несцентной активности нейтрофильных гранулоцитов у больных острым коронар¬ным синдромом. Сибирское медицинское обозрение 2012; 6: 21-4).

18. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med 2006; 3: 499-506.